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Heparan sulfate phage display antibodies
recognise epitopes deﬁned by a combination
of sugar sequence and cation binding
Valeria Solari,a Timothy R. Rudd,†a,b Scott E. Guimond,a Andrew K. Powell,c
Jeremy E. Turnbulla and Edwin A. Yatesa
Phage display antibodies are widely used to follow heparan sulfate (HS) expression in tissues and cells.
We demonstrate by ELISA, that cations alter phage display antibody binding proﬁles to HS and this is
mediated by changes in polysaccharide conformation, demonstrated by circular dichroism spec-
troscopy. Native HS structures, expressed on the cell surfaces of neuroblastoma and ﬁbroblast cells,
also exhibited altered antibody binding proﬁles following exposure to low mM concentrations of these
cations. Phage display antibodies recognise conformationally-deﬁned HS epitopes, rather than
sequence alone, as has been assumed, and resemble proteins in being sensitive to changes in both
charge distribution and conformation following binding of cations to HS polysaccharides.
1. Introduction
Heparan sulfate (HS) is a complex, naturally occurring, anionic
linear polysaccharide expressed on the cell surface of practi-
cally all mammalian cells and in the extracellular matrix
(ECM). It has been implicated in a wide range of cellular pro-
cesses, ranging from the promotion of cell signalling through
the fibroblast growth factor-receptor (FGF-FGFR) tyrosine
kinase pathway1 and Wnt signalling, to interactions with pro-
teins such as β-secretase-1 (BACE-1) and amyloid precursor
protein (APP), thought to be involved in Alzheimer’s disease,2,3
as well as in the attachment of pathogenic microorganisms to
host cells.4–10
HS is composed of 1,4 linked uronic acid residues (either
β-D-GlcA or its C-5 epimer, α-L-IdoA) alternating with α-D-GlcN.
The uronic acid can be 2-O-sulfated, while the glucosamine
bears a variety of substituents, which include 6-O-sulfate,
N-acetyl, N-sulfate and, more rarely, 3-O-sulfate groups. It was
first thought that the activities of HS would correlate with the
linear sequences of sugar residues but, the technical diﬃ-
culties associated with their extraction from tissue samples
and subsequent separation made direct exploration of this
possibility infeasible. Owing to the poor antigenicity of HS, a
library of semi-synthetic phage display antibodies was then
applied, with the aim of binding HS selectively.11 At its incep-
tion, the selectivity of the antibodies for HS was demonstrated
among a series of related glycosaminoglycans (GAGs), which
included HS as well as chondroitin sulfate (CS), hyaluronic
acid (HA) and the K-5 polysaccharide from E.coli. The utility of
the phage display library was demonstrated by labelling native
HS structures in kidney11 and, since then, the library has
become a widely used tool in glycobiology, amply demonstrat-
ing its ability to reveal HS expression patterns12 in many
tissues, including rat spleen,13 human kidney14 and developing
rat lungs.15
Several studies employing a range of both naturally occur-
ring and chemically modified HS structures and analogues
have attempted to delineate those HS sequences required for
binding to individual phage display antibodies and some
broad correlations have been determined. For example, the
antibody HS4C3 has been reported as requiring O- and
N-sulfate groups.12 It has been assumed generally, either tacitly
or explicitly, that the selectivity of the phage display antibodies
arises predominantly through direct recognition by the
peptide in the variable region, of negatively charged O-, N-sul-
fates and carboxylic acid groups of the HS, which amounts to
recognition of a particular sequence. However, it has recently
been realised that binding may be more complex; individual
antibodies recognising multiple HS structures.16 This is con-
sistent with the suggestion that a high degree of conformation-
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al redundancy exists in HS sequences, in terms of the glycosi-
dic linkage and uronate geometry.17 The consequences of this
are that it is possible for several distinct sequences to provide
conformational and charge features capable of being recog-
nised and bound. Although HS binding to cations is a well-
known phenomenon,18–20 it is only relatively recently that the
potential for cation binding by HS polysaccharides to drasti-
cally alter the biological activity of the polysaccharide, for
example in cell signaling,21,22 has become apparent. Following
these observations, which demonstrated that cation binding
by HS alters both the conformation and protein recognition
characteristics of the polysaccharide, the possibility that the
binding of cations to HS structures can also alter phage
display antibody binding was investigated. Phage display
antibodies HS3B7V12 and HS4E4V23 were both raised origi-
nally against bovine kidney HS and were selected for
several reasons. They both recognised HS but by distinct
epitopes, and their CDR-3 sequences, considered to be the
major determinants of specificity, were very diﬀerent, com-
prising SRKTRKPFMRK (6 basic residues out of 11) and
HAPLRNTRTNT (2 basic residues plus histidine out of 11),
respectively.16
2. Materials and methods
2.1 Biotinylation of chemically modified heparins and
enzyme-linked immunosorbent assay (ELISA)
50 μL of 50 mM N-hydroxysuccinimide amino caproate (LC)
biotin (NHS-LC biotin in DMSO) was added to 5 mg modified
heparin polysaccharide in water [bearing a small proportion of
free amine groups] and allowed to react overnight at room
temperature. Biotinylated polysaccharides were then separated
from the unconjugated biotin by dialysis (membrane, 3 kDa
cut-oﬀ ), freeze-dried and re-suspended in dH2O. Maxisorp 96-
well microtiter plates (Nunc; Roskilde, Denmark) were coated
(18 h, 4 °C) with 3 μg ml−1 streptavidin (Promega Ltd, South-
ampton, UK) in 0.1 M Na2CO3/HCO3 (pH 9.6) and blocked
with 1% (w/v) bovine serum albumin (BSA) in PBS (2 h, RT).
After washing with PBS, plates were incubated with the NHS-
biotinylated chemically modified heparin for 2 h. These were
HS polysaccharide analogues A and B containing both natural
and unnatural residues with predominant repeating disacchar-
ides IdoA2OH-GlcNS,6S and IdoA2S,3S-GlcNS,3S,6S respect-
ively. This was followed by an overnight incubation with
various cation preparations (CaCl2, CuCl2, ZnCl2, MgCl2, KCl
and NaCl at 100 mM, 10 mM and 1 mM; diluted in dH2O).
Plates were washed in PBS and incubated with the relevant
phage display antibody. The anti-VSV-G IgG, clone P5D4
(Sigma-Aldrich, UK; 1 : 500 dilution) was applied (1 h, RT) after
washing. HRP conjugated sheep anti-mouse IgG (1 : 1000) was
added after PBS washing (1 h). The reaction was visualized by
the addition of 50 μL O-phenylenediamine dihydrochloride
(OPD), the reaction stopped with 100 μl H2SO4 (0.5 M) and the
absorption measured at 490 nm. Biotinylated porcine mucosal
heparan sulfate and the omission of cations, omission of the
primary antibody and the anti-VSV tag antibody were used as
controls and all behaved as expected (results not shown). The
presence of cations on the polysaccharides prior to the experi-
ment or, introduced at any subsequent steps, and any possible
residual biotin in the polysaccharide preparations are not
responsible for diﬀerences in phage display antibody binding
because, if they are present, they are common to all experi-
mental cases.
2.2 Cell culture and immunofluorescence
The neuroblastoma cell line SH-SY5Y (#CRL 2266; ATCC, Rock-
ville, USA) was cultured in RPMI-1640 medium with 10% (v/v)
heat-inactivated foetal calf serum (FCS) and 1% non-essential
amino acids (NEAA) in a 37 °C incubator containing 5% CO2/
95% humidified air. Cells were plated at approximately 105
cells ml−1 on a 24 well cell culture plate, each containing an
8 mm round glass cover slip and grown for 24 h. Cells were
fixed in 4% paraformaldehyde in 0.1 M phosphate buﬀer (pH
7.4) for 10 min, rinsed in PBS and incubated overnight at 4 °C
with various cation solutions (section 2.1). The control cells
were incubated with PBS. After washing, cells were incubated
in 10% (v/v) goat serum in PBS (1 h) followed by an overnight
incubation at 4 °C with the relevant phage display antibody
diluted 1/10 (v/v). Bound antibody was detected using
rabbit VSV-G tag antibody (Sigma-Aldrich, UK) diluted 1 : 200
in 1% (v/v) goat serum in PBS. Alexa Fluor-488 conjugated goat
anti-rabbit IgG (Invitrogen, UK; 1 : 500 dilution) was incubated
for 1 h. Cells were washed with PBS and mounted in a fluo-
rescent mounting medium (Dako, Ely, UK). Negative controls
included omission of the phage display antibody against HS
and digestion of HS with heparinase I, II and III to remove the
HS epitopes prior to the antibody incubation, which were as
expected (results not shown). The samples were examined
under a confocal laser scanning microscope (TCS SPE, Leica,
UK) with excitation at 488 nm and UV for DAPI. As in the
ELISA experiment above (section 2.1), any cations that may
have been introduced during washing and incubation stages
were not responsible for any diﬀerences observed because they
were common to all experiments.
2.3 BaF assay of cell signalling through FGFR1c
BaF cells (a murine, IL-3 dependent mouse pro-B cell line) are
a useful model system with which to investigate the compe-
tence of an exogenous polysaccharide to support signalling
through a single fibroblast growth factor receptor (FGFR)
isoform and a single exogenously added fibroblast growth
factor (FGF).24 BaF cells (104 per well), transfected with a
chosen FGFR (FGFR1c) were incubated as described pre-
viously21,22 with polysaccharides (1 ng ml−1 to 10 μg ml−1) in
the chosen cation form. Briefly, cells were incubated (37 °C,
72 h), after which, 5 μL 3-[4,5-dimethylthiazol-2-yl]-2,5-diphe-
nyltetrazolium bromide (MTT) (5 mg ml−1 in PBS) was added
followed by a further 4 h incubation. Cells were then solubil-
ized [10% SDS, 0.1 N HCl] and the absorbance at 570 nm was
measured.
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2.4 Detection of conformational change in polysaccharides
using circular dichroism spectroscopy
Circular dichroism spectroscopy (CD) is a technique that is
sensitive to conformational changes (particularly the environ-
ment of the carboxylate groups of the uronic acids) in GAG
polysaccharides in solution and measures the diﬀerential
absorbance of right and left-circularly polarised light. CD
spectra were recorded on a purpose-built synchrotron CD
beam line employing a quartz sample cell of 0.02 cm path
length and 1 nm resolution. Spectra are presented as molar cir-
cular dichroism (per mole per cm) and were corrected for
diﬀerences in molecular weight according to composition
analysis.25,26
2.5 Characterisation of polysaccharides A and B
Polysaccharides A and B were prepared as described (ref. 28
and 27 respectively) from porcine mucosal heparin (Celsus
Labs, Cincinnati, OH, USA) and purified by size-exclusion
chromatography (Sephadex G-25, recovering only the exclusion
limit, Mw > 5 kDa). Major disaccharides in polysaccharide A
(%) were detected following exhaustive digestion, fluorescence
labelling with BODIPY hydrazide and HPAEC analysis with
reference to authentic standards (ProPac PA-1 column, Dionex
UK) as ΔUA-GlcNAc 31.7, ΔUA-GlcNS 23.7, ΔUA-GlcNS(6S)
44.6.26 Polysaccharides A and B were also characterised by
NMR spectroscopy (D2O, 40 °C, chemical shift values recorded
relative to trimethylsilyl propionate as standard.27,28 Polysac-
charide A: 1H NMR(ppm): (glucosamine) H-1 5.34, H-2 3.26,
H-3 3.65, H-4 3.71 H-5 4.02, H-6,6′ 4.36–4.23 (iduronate) H-1
5.04, H-2 3.78, H-3 4.12, H-4 4.08, H-5 4.84. 13C NMR (ppm):
(glucosamine) C-1 98.1, C-2 60.3, C-3 72.4, C-4 80.1, C-5 71.5,
C-6 68.7 (iduronate) C-1 104.6, C-2 71.1, C-3 70.4, C-4 77.2, C-5
71.2. Polysaccharide B: 1H NMR (ppm): (glucosamine) H-1
5.32, H-2 3.50, H-3 4.48, H-4 4.04, H-5 4.05, H-6,6′ 4.27–4.41
(iduronate) H-1 5.32, H-2 4.55, H-3 4.72, H-4 4.39, H-5 5.05.
13C NMR(ppm): (glucosamine) C-1 99.6, C-2 59.3, C-3 82.9, C-4
76.8, C-5 72.1, C-6 68.7 (iduronate) C-1100.8, C-2 73.6, C-3
72.9, C-4 73.3, C-5 68.7. Changes in conformation and rigidity
in polysaccharide A were corroborated by altered NOE values
between protons in the structure and by altered T2 relaxation
rates following cation exchange. For example, comparing Na
and Ca forms of polysaccharide A, NOE values were as follows:
A-1 to I-3; 12.5 (Na) and 10.5 (Ca); I-1 to A-6; 7.3 (Na) and 3.8
(Ca); I-1 to A-6′ 4.0 (Na) and 2.9 (Ca); I-5 to I-2; 2.8 (Na) and 0.8
(Ca). T2 relaxation times (ms) at selected positions: A-1 130
(Na) and 94 (Ca), A-2 135 (Na) and 105 (Ca), I-1 113 (Na) and
52 (Ca), I-2 95 (Na) and 59 (Ca).22
3. Results
3.1 Cations alter the binding of phage display antibodies to
heparan sulfate
To examine the eﬀects of cations on the binding of phage
display antibodies to HS, a modification of an ELISA assay pre-
viously reported16 was employed, in which the polysaccharides
were first exposed to various cations before application of the
phage display antibodies. Briefly, the polysaccharides were
converted to the appropriate cation form by use of excess
cation exchange resin (Dowex W-50) that had been converted
from the acidic form to the appropriate cation form using a
solution of the chloride of the metal ion concerned.21,22
Any diﬀerences observed cannot have arisen from residual
cations or those that might have been introduced by sub-
sequent washing or incubation steps because these procedures
were common to all the experiments. The exposure to physio-
logically relevant divalent cations such as Mg, Ca, Cu(II)
and Zn altered the binding of the phage display antibody
HS3B7V to model HS polysaccharide analogues A and B predo-
minantly containing, respectively, the natural occurring disac-
charide repeat IdoA-GlcNS,6S [Fig. 1A] and the unnatural over-
sulfated residues IdoA2S,3S-GlcNS,3S,6S [Fig. 1B]. Polysacchar-
ide B, was included because it has been shown recently that
such structures can mimic HS sequences in protein binding
and activity.29 Their recognition by phage display antibodies
supports the assertion that their conformation and charge
characteristics can be similar to HS.
Fig. 1 ELISA establishing that exposure to cations alters the binding of
phage display antibody HS3B7V to model GAG polysaccharides contain-
ing the naturally occurring disaccharide residue [IdoA-GlcNS,6S – poly-
saccharide A] (A) and over-sulfated residues [IdoA2S,3S-GlcNS,3S,6S –
polysaccharide B], (B) respectively. In accord with the higher confor-
mational ﬂexibility of analogue A, the eﬀect of cation binding is com-
plex and varies with concentration but, is more uniformly increased
and shows fewer subtleties with the more highly sulfated and rigid ana-
logue B.
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The eﬀect of the cations on antibody binding were complex,
particularly to polysaccharide A, with both increases and
decreases in binding being observed. This is because subtle
changes in conformation and charge distribution result from
interactions with varying levels of cations. For instance, a Ca
concentration of 100 mM resulted in the lowest binding of
analogue A to antibody HS3B7V [Fig. 1A], whereas a reduced
cation concentration of 1 mM showed more uniform but
increased binding to analogue B [Fig. 1B]. A high Zn concen-
tration (100 mM) also caused decreased antibody binding to
analogue A [Fig. 1A].
The binding of cations by HS and potential changes in recog-
nition profiles by phage display antibodies is of considerable
importance because the concentration of common cations
(Na, K, Mg and Ca) and some transition metal ions (e.g. Cu(II)
and Zn) are known to vary considerably between tissues and
under diﬀerent physiological conditions (see Discussion
below).
Having demonstrated altered phage display antibody
binding to diﬀerent cation forms of HS analogue structures,
the binding profiles of the antibodies were examined to deter-
mine whether cations can also modify their binding to
heparan sulfate on cell surfaces. Immunofluorescence,
employing the antibodies applied to neuroblastoma cells, that
had been exposed following fixing to a variety of concen-
trations of cations, was employed [Fig. 2]. Immunostaining
revealed higher expression of the antibodies HS3B7V and
HS4E4V after divalent cation exposure compared to exposure
to PBS (divalent ion free) alone. A variety of binding patterns
were evident; for example, diﬀuse cell surface binding of
HS3B7V to cells treated with Ca and Zn [Fig. 2F and H],
binding (including punctate binding) of HS4E4V in Zn treated
cells to filopodia [Fig. 2D] and localisation, including to cell–
cell contacts with HS3B7V for Cu and Zn treated cells [Fig. 2G
and H]. In some cases, the results of treatment with two
cations were similar, for example, Ca and Zn [Fig. 2F and H] at
10 mM. Controls included the omission of the primary HS
antibodies (no staining: images not shown). These data
support the notion that the binding of cations by HS can alter
the binding of cell surface HS by phage display antibodies.
3.2 The binding of cations to polysaccharide A with the
predominant repeating unit [IdoA-GlcNS,6S] alters both its
conformation and biological activity
The results above suggested that the propensity for cations to
alter conformation and/or binding properties and potentially
alter biological activity is a general characteristic of these poly-
saccharides. That the binding of cations to HS polysaccharides
can result in altered conformation was demonstrated by the
change in circular dichroism (CD) spectrum of analogue A
[Fig. 3A]. CD in the far UV (170–250 nm) is sensitive to the con-
formational environment of the chromophores (n–π* and π–π*
transitions in the CvO bonds of carboxylic acids and N-acetyl
groups of GAGs22). A change in CD on addition of cations
demonstrates a change in the conformation around these
chromophores, which could comprise, for example, altered gly-
cosidic geometry, a change in the sugar ring (chair or skew-
boat) or sulfate conformation, or a combination of these
Fig. 2 Exposure of native cell surface HS structures to a variety of physiologically relevant cations alter phage display antibody binding proﬁles. The
binding of phage display antibodies HS4E4V [A to D] and HS3B7V [E to H] to HS on the surface of ﬁxed, cultured SH-SY5Y neuroblastoma cells was
altered by exposure to divalent cations at 10 mM. A and E, show HS expression following exposure to PBS free of Ca and Mg ions (divalent ion free);
B and F, following exposure to Ca ions; C and G to Cu ions (10 mM). D and H are after exposure to Zn ions (10 mM). Original magniﬁcation ×40.
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factors. Furthermore, any changes observed by CD are chiral in
nature and are likely to result in altered protein binding.
4. Discussion
The binding of HS by phage display antibodies (and proteins
more generally) has been viewed conventionally as involving
interactions between a series of negatively charged groups (car-
boxylic acids, N- and O-sulfates on HS) and regions on the
protein surface, especially but not exclusively containing posi-
tively charged amino acid side chains such as lysine and argi-
nine. However, the binding patterns of phage display
antibodies to HS are clearly complex, with previous work
showing that multiple HS structures bind the basic surfaces
on the variable regions of the antibodies.16 Here, we have
shown that cation binding to several polysaccharides, both to
HS analogues in microwells and HS on a cell surface, resulted
in altered phage display antibody binding for several phage
display antibodies. It is therefore reasonable to conclude that
this is a general property of this system. While we show that
cation binding can alter the conformation of the polysacchar-
ide, it is also possible that cation binding to the antibody
could contribute to a change in recognition characteristics,
although the latter possibility is much more diﬃcult to assess
experimentally. For example, in ELISA assays for HS3B7V
binding to HS analogue A [Fig. 1A], serving as a model of HS
and containing the naturally occurring, predominant repeating
disaccharide [IdoA-GlcNS,6S], it is noteworthy that binding is
modified in a complex manner, increasing or decreasing as a
function of cation concentration. This is the consequence of
the subtle interplay between cation and polysaccharide confor-
mation, flexibility and charge distribution. The detailed
measurement of cation binding rates and aﬃnities are very
diﬃcult to address and lie outside the scope of this paper,
although some work has been done.18,19,30 Copper(II) ions
exhibit an unusually specific interaction and mode of binding
with the highly sulfated residues of heparin, containing the
motif IdoA2S-GlcNS,6S binding the ion in a four-fold planar
arrangement.31 The broader applicability of the eﬀect of
cations on polysaccharide structure and subsequent phage
display antibody binding was then examined for the case of a
non-natural, sulfated polysaccharide, containing over-sulfated
sequences, analogue B. In this case, the binding of HS3B7V
was increased for all cations tested, but, less variation was
observed. This polysaccharide, provides a comparison with the
more flexible analogue A because, while being active in several
assays in which HS and heparin act, it is considered to be rela-
tively rigid compared to other GAGs (and considerably more
rigid than uncharged and branched structures) due to steric
hindrance.27 Furthermore, since such analogues have been
shown to be capable of inducing changes in protein structure
and biological activity,29 and the phenomenon of phage
display antibody binding is also aﬀected by cations, this
suggests potential for their use in other recognition roles,
including identification of HS mimics.
The eﬀect of cations has also been demonstrated for phage
display antibodies HS4E4V and HS3B7V on the cell surface of
cultured SH-SY5Y neuroblastoma cells (an aggressive child-
hood cancer originating in the neural crest and associated
with metastasis and poor outcome) following exposure to low
mM levels of cations [Fig. 2]. That the binding of cations to HS
polysaccharides can alter the conformation, was demonstrated
here by the change in CD spectrum of analogue A [Fig. 3A].
This causes both the antibody binding profiles [Fig. 1] and the
biological activity to change [Fig. 3B]. There is also the possi-
bility that particular charged groups may be shielded by the
presence of particular cations, which would be consistent with
the sensitivity of HS4E4 and HS4C3 to changes in 2-O-sulfa-
tion,32 although the ability of divalent cations to form bridges
between the polysaccharide and the binding peptide region
may be an additional factor. These findings suggest that the
propensity for cations to alter conformation and/or binding
properties and, in certain cases, to subsequently alter biologi-
cal activity, is a general characteristic of these molecules, but
one to which phage display antibodies are sensitive.
Fig. 3 A. Circular dichroism spectrum demonstrating changes in con-
formation of analogue A following exposure to cations [Na, K, Mg, Ca,
Cu(II)]. CD reports the diﬀerential absorbance of right and left circularly
polarized light in the UV region and is highly sensitive to changes in the
chiral conformation of the chromophores. B. In a BaF cell assay, in
which the only available route for cell signaling is via the transfected
FGFR1c and exogenously added FGF-1 and polysaccharide, the ability of
analogue A to support FGF signaling changes and depends on the cation
form of the polysaccharide. The polysaccharide A:cation complexes are
compared to sodium heparin [I2S A
6S
NS:Na].
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During the original selection of phage display antibodies
e.g.11 the cations present during binding to the kidney HS were
not determined and, although the HS had been subjected to
anion exchange chromatography involving sodium chloride, so
was likely to be predominantly in the sodium form initially,
subsequent steps in the selection process will have introduced
other cations into the system.
There are many instances in which the concentration of
common physiological cations may vary in cells, on their sur-
faces as well as in the extracellular matrix, and imbalances can
have serious physiological consequences. Calcium levels are
regulated by ion-pumps but, calcium imbalance is known to
be involved in several pathological processes including
cancer.33 Less common but, nevertheless, essential cations
such as Cu and Zn, also play important roles in normal
and disease physiology. Copper in its free form is extremely
toxic, in part a consequence of its ability to propagate free radi-
cals via the Fenton reaction, and is transported by an elabo-
rate mechanism.34 Failure to regulate copper levels results in
severe illness, for example, Menkes’ and Wilson’s diseases,
during which levels in the liver can reach 250 μg g−1.35
The liver contains HS that is rich in highly sulfated
IdoA2S-GlcNS,6S residues, which are known to bind Cu(II) ions
at a specific site31,33 and also high levels of IdoA-GlcNS,6S
(mimicked by HS analogue A in this work).36 This latter repeat-
ing disaccharide has also been reported in diabetic kidney.37
Altered levels of Zn are a feature of ageing38 and neurodegen-
erative disease,39 while GAG expression is also known to vary40
and both potassium and calcium levels have been related to
ageing in Drosophila.41 The levels of cations and expression of
HS structures both vary considerably during normal and
disease processes and here, the detection of GAG structures
using phage display antibodies is aﬀected by cation levels.
Phage display antibody HS4C3 has been shown to bind a
sequence comprising predominantly [Ido-GlcNS,6S] residues, in
associated with metal ions [Fig. 1A] confirming that antibodies
can bind to several distinct combinations of sequence42 and
cation. This is perhaps less surprising when viewed in light of
the recently suggested high level of redundancy in HS struc-
tures29 and confirms that a degree of conformational degeneracy
is indeed present in interactions between these short peptide
sequences and regions of HS. Recognition of negatively charged
groups on HS by positively charged amino-acids in the short
peptide stretches may also require a compatible overall confor-
mation and binding divalent cations in particular could provide
a means by which compatibility can be attained for a variety of
sequences. This principle could be relevant to the interactions of
full-length proteins with HS and other GAGs.
The influence of cation binding on the conformation of
other biological macromolecules has been documented for
proteins43,44 and for DNA.45 The present findings for HS poly-
saccharides could have important implications for the
interpretation of HS expression profiles in tissues using these
antibodies and suggest that phage display antibodies may
enable protein binding profiles to HS to be followed more
closely than previously realised.
It is also noteworthy that structures which do not occur
naturally, such as that with the predominant repeating disac-
charide structure of analogue B, [IdoA2S,3S-GlcNS,3S,6S] can,
nevertheless, still adopt suitable conformational and charge
distribution arrangements to allow binding of phage display
antibodies, as they have been shown to do with intact pro-
teins.29 Such synthetic polysaccharide structures are also sus-
ceptible to influence by cation binding and the resulting
conformational and binding consequences [Fig. 1A and B].
This supports the idea that complementary surfaces, defined
by the combined eﬀects of sequence, cation binding and their
conformational consequences, define the recognition element
in HS for antibodies and proteins.
5. Conclusions
In any search for characteristics by which diﬀerent areas of a
cell or tissue can be diﬀerentiated, it is desirable to follow
functional properties, rather than expression based solely on
the detection of sequences, especially when the latter requires
some form of interpretation dependent on a knowledge of
structure–function relationships, which is often absent or, at
best, only partial. We suggest that these antibodies may
provide a functional read-out in the sense that their binding
provides a means of tracking the protein binding profile of HS
which, in tissues as elsewhere, exist in association with
cations. In conclusion, the phage display antibody library
recognises the overall conformation of HS structures with their
associated cations and it is this, ultimately, that is relevant to
protein binding and function.
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